At the request of the authors, and with the agreement of the journal editors, the following article has been retracted and is re-published as open access in April 2022.
Muhanmode Y, Wen MK, Maitinuri A, Shen G (2021) Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway. Human & Experimental Toxicology 40(12S): S861–S868. DOI: 10.1177/09603271211052985
References
1.
ZhangYLuoGLiM, et al.Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. BMC Cancer2019; 19(1): 984. DOI: 10.1186/s12885-019-6139-6. PMID: 31640608; PMCID: PMC6806513.
2.
Gaona-LuvianoPMedina-GaonaLAMagaña-PérezK. Epidemiology of ovarian cancer. Chin Clin Oncol2020; 9(4): 47. DOI: 10.21037/cco-20-34. Epub 2020 Jun 30. PMID: 32648448.
3.
CorradettiBPisanoSConlanRS, et al.Nanotechnology and immunotherapy in ovarian cancer: tracing new landscapes. J Pharmacol Exp Ther2019; 370(3): 636–646. DOI: 10.1124/jpet.118.254979. Epub 2019 Feb 8. PMID: 30737357; PMCID: PMC6806629.
4.
KanlikilicerPBayraktarRDenizliM, et al.Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer. EBioMedicine2018; 38: 100–112. DOI: 10.1016/j.ebiom.2018.11.004. Epub 2018 Nov 25. Erratum in: EBioMedicine. 2020 Feb;52:102630. PMID: 30487062; PMCID: PMC6306310.
5.
ZhangLYChenYJiaJ, et al.MiR-27a promotes EMT in ovarian cancer through active Wnt/β-catenin signalling by targeting FOXO1. Cancer Biomark2019; 24(1): 31–42. DOI: 10.3233/CBM-181229. PMID: 30614794.
6.
LupiaMAngioliniFBertalotG, et al.CD73 regulates stemness and epithelial-mesenchymal transition in ovarian cancer-initiating cells. Stem Cell Rep2018; 10(4): 1412–1425. DOI: 10.1016/j.stemcr.2018.02.009. Epub 2018 Mar 15. PMID: 29551673; PMCID: PMC5998305.
7.
AhmedNKadifeERazaA, et al.Ovarian cancer, cancer stem cells and current treatment strategies: a potential role of magmas in the current treatment methods. Cells2020; 9(3): 719. DOI: 10.3390/cells9030719. PMID: 32183385; PMCID: PMC7140629.
8.
EdiriweeraMKTennekoonKHSamarakoonSR. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol2019; 59: 147–160. DOI: 10.1016/j.semcancer.2019.05.012. Epub 2019 May 22. PMID: 31128298.
9.
CheaibBAugusteALearyA. The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges. Chin J Cancer2015; 34(1): 4–16. DOI: 10.5732/cjc.014.10289. PMID: 25556614; PMCID: PMC4302085.
10.
WeiXJiaYLouH, et al.Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway. Oncol Rep2019; 42(6): 2768–2776. DOI: 10.3892/or.2019.7370. Epub 2019 Oct 14. PMID: 31638241.
11.
McCubreyJALertpiriyapongKSteelmanLS, et al.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY)2017; 9(6): 1477–1536. DOI: 10.18632/aging.101250. PMID: 28611316; PMCID: PMC5509453.
12.
HuangMLiangCTanC, et al.Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol. Food Funct2019; 10(10): 6447–6458. DOI: 10.1039/c9fo01338e. PMID: 31524893.
13.
ZhangLXueHZhaoG, et al.Curcumin and resveratrol suppress dextran sulfate sodium-induced colitis in mice. Mol Med Rep2019; 19(4): 3053–3060. DOI: 10.3892/mmr.2019.9974. Epub 2019 Feb 20. PMID: 30816479; PMCID: PMC6423642.
14.
D’ArcyMS. A review of the chemopreventative and chemotherapeutic properties of the phytochemicals berberine, resveratrol and curcumin, and their influence on cell death via the pathways of apoptosis and autophagy. Cell Biol Int2020; 44(9): 1781–1791. DOI: 10.1002/cbin.11402. Epub 2020 Jun 10. PMID: 32449796.
15.
HanZJFengYHGuBH, et al.The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol2018; 52(4): 1081–1094. DOI: 10.3892/ijo.2018.4280. Epub 2018 Feb 22. PMID: 29484374; PMCID: PMC5843405.
16.
Serrano-GomezSJMaziveyiMAlahariSK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer2016; 15: 18. DOI: 10.1186/s12943-016-0502-x. PMID: 26905733; PMCID: PMC4765192.
17.
MalhotraANairPDhawanDK. Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis. PLoS One2014; 9(4): e93820. DOI: 10.1371/journal.pone.0093820. PMID: 24705375; PMCID: PMC3976304.
18.
NiJCozziPJHaoJL, et al.CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance. The Prostate2014; 74: 602–617.
19.
HaoJMadiganMCKhatriA, et al.In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147. PLoS One2012; 7: e40716.
20.
LowryOHRorebroughNJFarrAL, et al.Protein measurement with the folin phenol reagent. J Biol Chem1951; 93: 265–275.
21.
ChangLGrahamPHHaoJ, et al.Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Disease2013; 4: e875.
22.
CalafGMPonce-CusiRCarriónF. Curcumin and paclitaxel induce cell death in breast cancer cell lines. Oncol Rep2018; 40(4): 2381–2388. DOI: 10.3892/or.2018.6603. Epub 2018 Jul 26. PMID: 30066930.
23.
JoeAKLiuHSuzuiM, et al.Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res2002; 8(3): 893–903. PMID: 11895924
24.
ChaoHWangLHaoJ, et al.Low dose histone deacetylase inhibitor, LBH589, potentiates anticancer effect of docetaxel in epithelial ovarian cancer via PI3K/Akt pathway in vitro. Cancer Letters2013; 329: 17–26.
25.
Bayat MokhtariRHomayouniTSBaluchN, et al.Combination therapy in combating cancer. Oncotarget2017; 8(23): 38022–38043. DOI: 10.18632/oncotarget.16723. PMID: 28410237; PMCID: PMC5514969.
26.
MajiSPandaSSamalSK, et al.Bcl-2 antiapoptotic family proteins and chemoresistance in cancer. Adv Cancer Res2018; 137: 37–75. DOI: 10.1016/bs.acr.2017.11.001. Epub 2017 Dec 6. PMID: 29405977.
27.
ZhangFWangHYuJ, et al.LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer2021; 20(1): 6. DOI: 10.1186/s12943-020-01299-y. PMID: 33397371; PMCID: PMC7780690.
28.
BarbatoLBocchettiMDi BiaseA, et al. Cancer Stem Cells and Targeting Strategies. Cells2019; 8(8): 926. DOI: 10.3390/cells8080926. PMID: 31426611; PMCID: PMC6721823.
29.
ZhengXCarstensJLKimJ, et al.Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature2015; 527(7579): 525–530. DOI: 10.1038/nature16064. Epub 2015 Nov 11. PMID: 26560028; PMCID: PMC4849281.
30.
XuHYuWBGaoY, et al.Modulatory potential of curcumin and resveratrol on p53 post-translational modifications during gastric cancer. J Environ Pathol Toxicol Oncol2018; 37(2): 93–101. DOI: 10.1615/JEnvironPatholToxicolOncol.2018025547. PMID: 30055545.
31.
NiedzwieckiARoomiMWKalinovskyT, et al. Anticancer efficacy of polyphenols and their combinations. Nutrients2016; 8(9): 552. DOI: 10.3390/nu8090552. PMID: 27618095; PMCID: PMC5037537.
32.
MohapatraPSatapathySRSiddharthS, et al.Resveratrol and curcumin synergistically induces apoptosis in cigarette smoke condensate transformed breast epithelial cells through a p21(Waf1/Cip1) mediated inhibition of Hh-Gli signaling. Int J Biochem Cell Biol2015; 66: 75–84. DOI: 10.1016/j.biocel.2015.07.009. Epub 2015 Jul 23. PMID: 26212257.
33.
GavrilasLICruceriuDIonescuC, et al.Pro-apoptotic genes as new targets for single and combinatorial treatments with resveratrol and curcumin in colorectal cancer. Food Funct2019; 10(6): 3717–3726. DOI: 10.1039/c9fo01014a. PMID: 31169275.
34.
MalhotraANairPDhawanDK. Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis. Hum Exp Toxicol2012; 31(12): 1199–1206. DOI: 10.1177/0960327112440113. Epub 2012 Apr 24. PMID: 22531968.
